Patterns of use of hemostatic agents in patients undergoing major surgery

Journal of Surgical Research

Volumn 186, Issue 1, 2014, Pages 458-466

  Wright, Jason D ^a,b   Ananth, Cande V ^a   Lewin, Sharyn N ^a,b   Burke, William M ^a   Siddiq, Zainab ^a   Neugut, Alfred I ^a,b,c   Herzog, Thomas J ^a,b   Hershman, Dawn L ^a,b,c  

^a Columbia University College of Physicians and Surgeons ^*  (United States)

^b Department of Medicine   (United States)

^c Department of Medicine   (United States)

Author keywords

Bleeding; Blood; Hemorrhage; Hemostasis; Hemostatic agents

Indexed keywords

ADHESIVE AGENT; FIBRIN; HEMOSTATIC AGENT; SEALANT; THROMBIN;

ADULT; ARTICLE; BLOOD; BLOOD TRANSFUSION; CLINICAL PRACTICE; COLON RESECTION; CORONARY ARTERY BYPASS GRAFT; DRUG USE; FEMALE; GASTRECTOMY; HIP ARTHROPLASTY; HUMAN; HYSTERECTOMY; KNEE ARTHROPLASTY; LIVER RESECTION; LUNG RESECTION; MAJOR CLINICAL STUDY; MAJOR SURGERY; MALE; NEPHRECTOMY; PANCREAS RESECTION; PRIORITY JOURNAL; PROSTATECTOMY; SPINE SURGERY; SURGICAL TECHNIQUE; THYROIDECTOMY; VALVULOPLASTY;

BLEEDING; BLOOD; HEMORRHAGE; HEMOSTASIS; HEMOSTATIC AGENTS;

ADULT; AGED; BLOOD LOSS, SURGICAL; BLOOD TRANSFUSION; FEMALE; HEMOSTATICS; HUMANS; MALE; MIDDLE AGED; SURGICAL PROCEDURES, OPERATIVE;

EID: 84890128584     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2013.07.042     Document Type: Article

References (43)

1. K. Karkouti, and K.M. Dattilo Perioperative hemostasis and thrombosis Can J Anaesth 53 2006 1260
2. K. Karkouti, D.N. Wijeysundera, and T.M. Yau The independent association of massive blood loss with mortality in cardiac surgery Transfusion 44 2004 1453
3. P.A. Carless, D.A. Henry, and D.M. Anthony Fibrin sealant use for minimising peri-operative allogeneic blood transfusion Cochrane Database Syst Rev 2003 CD004171
4. P.B. Hasley, J.R. Lave, and B.H. Hanusa Variation in the use of red blood cell transfusions. A study of four common medical and surgical conditions Med Care 33 1995 1145
5. J.E. Hendrickson, and C.D. Hillyer Noninfectious serious hazards of transfusion Anesth Analg 108 2009 759
6. P.A. Carless, D.A. Henry, J.L. Carson, P.P. Hebert, B. McClelland, and K. Ker Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion Cochrane Database Syst Rev 2010 CD002042
7. J.L. Vincent, J.F. Baron, and K. Reinhart Anemia and blood transfusion in critically ill patients JAMA 288 2002 1499
8. W.D. Spotnitz, and S. Burks State-of-the-art review: hemostats, sealants, and adhesives II: update as well as how and when to use the components of the surgical toolbox Clin Appl Thromb Hemost 16 2010 497
9. W.D. Spotnitz, and S. Burks Hemostats, sealants, and adhesives: components of the surgical toolbox Transfusion 48 2008 1502
10. Y.M. Hong, and K.R. Loughlin The use of hemostatic agents and sealants in urology J Urol 176 2006 2367
11. P.A. Carless, D.M. Anthony, and D.A. Henry Systematic review of the use of fibrin sealant to minimize perioperative allogeneic blood transfusion Br J Surg 89 2002 695
12. T. Lagu, M.B. Rothberg, B.H. Nathanson, P.S. Pekow, J.S. Steingrub, and P.K. Lindenauer The relationship between hospital spending and mortality in patients with sepsis Arch Intern Med 171 2011 292
13. P.K. Lindenauer, P. Pekow, K. Wang, D.K. Mamidi, B. Gutierrez, and E.M. Benjamin Perioperative beta-blocker therapy and mortality after major noncardiac surgery N Engl J Med 353 2005 349
14. P.K. Lindenauer, P.S. Pekow, M.C. Lahti, Y. Lee, E.M. Benjamin, and M.B. Rothberg Association of corticosteroid dose and route of administration with risk of treatment failure in acute exacerbation of chronic obstructive pulmonary disease JAMA 303 2010 2359
15. J.D. Wright, C.V. Ananth, and S.N. Lewin Robotically assisted vs laparoscopic hysterectomy among women with benign gynecologic disease JAMA 309 2013 689
16. J.D. Wright, A.I. Neugut, and C.V. Ananth Deviations from guideline-based therapy for febrile neutropenia in cancer patients and their effect on outcomes JAMA Intern Med 173 2013 559
17. M.E. Charlson, P. Pompei, K.L. Ales, and C.R. MacKenzie A new method of classifying prognostic comorbidity in longitudinal studies: development and validation J Chronic Dis 40 1987 373
18. R.A. Deyo, D.C. Cherkin, and M.A. Ciol Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases J Clin Epidemiol 45 1992 613
19. B.K. Hollenbeck, Y. Wei, and J.D. Birkmeyer Volume, process of care, and operative mortality for cystectomy for bladder cancer Urology 69 2007 871
20. J.D. Birkmeyer, Y. Sun, S.L. Wong, and T.A. Stukel Hospital volume and late survival after cancer surgery Ann Surg 245 2007 777
21. P.A. Carless, D.A. Henry, and A.J. Moxey Desmopressin for minimising perioperative allogeneic blood transfusion Cochrane Database Syst Rev 2004 CD001884
22. J.B. Segal, E. Blasco-Colmenares, E.J. Norris, and E. Guallar Preoperative acute normovolemic hemodilution: a meta-analysis Transfusion 44 2004 632
23. P.A. Carless, D.A. Henry, A.J. Moxey, D. O'Connell, T. Brown, and D.A. Fergusson Cell salvage for minimising perioperative allogeneic blood transfusion Cochrane Database Syst Rev 2010 CD001888
24. D.A. Henry, P.A. Carless, and A.J. Moxey Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion Cochrane Database Syst Rev 2011 CD001886
25. J. Figueras, L. Llado, and M. Miro Application of fibrin glue sealant after hepatectomy does not seem justified: results of a randomized study in 300 patients Ann Surg 245 2007 536
26. M. Mawatari, T. Higo, Y. Tsutsumi, M. Shigematsu, and T. Hotokebuchi Effectiveness of autologous fibrin tissue adhesive in reducing postoperative blood loss during total hip arthroplasty: a prospective randomised study of 100 cases J Orthop Surg (Hong Kong) 14 2006 117
27. L.M. Taylor Jr., G. Mueller-Velten, A. Koslow, G. Hunter, T. Naslund, and R. Kline Prospective randomized multicenter trial of fibrin sealant versus thrombin-soaked gelatin sponge for suture- or needle-hole bleeding from polytetrafluoroethylene femoral artery grafts J Vasc Surg 38 2003 766
28. T. Fabian, J.A. Federico, and R.B. Ponn Fibrin glue in pulmonary resection: a prospective, randomized, blinded study Ann Thorac Surg 75 2003 1587
29. C. Doria, C.P. Fischer, C.G. Wood, P.M. Li, S. Marra, and J. Hart Phase 3, randomized, double-blind study of plasma-derived human thrombin versus bovine thrombin in achieving hemostasis in patients undergoing surgery Curr Med Res Opin 24 2008 785
30. D.A. Henry, K.M. Henderson, J.L. Fryer, C.J. Treloar, K.M. McGrath, and S.F. Deveridge Use of interventions to minimise perioperative allogeneic blood transfusion in Australia. A survey by the International Study of Perioperative Transfusion (ISPOT) Study Group Med J Aust 172 2000 365
31. D. Fergusson, A. Blair, and D. Henry Technologies to minimize blood transfusion in cardiac and orthopedic surgery. Results of a practice variation survey in nine countries. International Study of Peri-operative Transfusion (ISPOT) Investigators Int J Technol Assess Health Care 15 1999 717
32. I.D. Graham, D. Fergusson, L. McAuley, and A. Laupacis The use of technologies to minimize exposure to perioperative allogeneic blood transfusion in elective surgery. A survey of Canadian hospitals Int J Technol Assess Health Care 16 2000 228
33. E. Katz, L. Gaitini, M. Samri, N. Egoz, D. Fergusson, and A. Laupacis The use of technologies to decrease peri-operative allogenic blood transfusion: results of practice variation in Israel Isr Med Assoc J 3 2001 809
34. A.B. Hutchinson, D. Fergusson, I.D. Graham, A. Laupacis, J. Herrin, and C.D. Hillyer Utilization of technologies to reduce allogeneic blood transfusion in the United States Transfus Med 11 2001 79
35. A.C. Logan, V. Yank, and R.S. Stafford Off-label use of recombinant factor VIIa in U.S. hospitals: analysis of hospital records Ann Intern Med 154 2011 516
36. A.D. Shaw, M. Stafford-Smith, and W.D. White The effect of aprotinin on outcome after coronary-artery bypass grafting N Engl J Med 358 2008 784
37. D.T. Mangano, I.C. Tudor, and C. Dietzel The risk associated with aprotinin in cardiac surgery N Engl J Med 354 2006 353
38. J. Avorn, and A. Kesselheim A hemorrhage of off-label use Ann Intern Med 154 2011 566
39. D.C. Radley, S.N. Finkelstein, and R.S. Stafford Off-label prescribing among office-based physicians Arch Intern Med 166 2006 1021
40. D. Leveque Off-label use of anticancer drugs Lancet Oncol 9 2008 1102
41. J.D. Wright, A.I. Neugut, and E.T. Wilde Physician characteristics and variability of erythropoiesis-stimulating agent use among Medicare patients with cancer J Clin Oncol 29 2011 3408
42. V. Yank, C.V. Tuohy, and A.C. Logan Systematic review: benefits and harms of in-hospital use of recombinant factor VIIa for off-label indications Ann Intern Med 154 2011 529
43. M.B. Rothberg, P.S. Pekow, M. Lahti, O. Brody, D.J. Skiest, and P.K. Lindenauer Antibiotic therapy and treatment failure in patients hospitalized for acute exacerbations of chronic obstructive pulmonary disease JAMA 303 2010 2035